Oncology GI Cancers Biliary 2nd Line +
Categories
Protocols
DAIICHI-SANKYO-DS3939-077 Phase I/II OPEN TO ACCRUAL
A Phase 1/2, Open-Label, Multicenter, First-in-Human Study of DS-3939a in Subjects with Advanced Solid Tumors